Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
16144 | 604 | 37.6 | 77% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
222 | 19941 | LYMPHANGIOGENESIS//ANGIOGENESIS//ENDOSTATIN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CORNEAL NEOVASCULARIZATION | Author keyword | 134 | 63% | 22% | 134 |
2 | LIPID KERATOPATHY | Author keyword | 8 | 56% | 2% | 10 |
3 | HEMANGIOGENESIS | Author keyword | 7 | 53% | 1% | 9 |
4 | SUBCONJUNCTIVAL BEVACIZUMAB | Author keyword | 6 | 71% | 1% | 5 |
5 | CORNEAL ANGIOGENESIS | Author keyword | 5 | 54% | 1% | 7 |
6 | ANECORTAVE ACETATE | Author keyword | 4 | 39% | 1% | 9 |
7 | CORNEAL LYMPHANGIOGENESIS | Author keyword | 4 | 75% | 0% | 3 |
8 | CORNEAL NEOVASCULARISATION | Author keyword | 3 | 50% | 1% | 4 |
9 | CORNEAL TISSUE ENGN STEM CELL BIOL | Address | 2 | 33% | 1% | 6 |
10 | BETA CYCLODEXTRIN TETRADECASULFATE | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TOPICAL BEVACIZUMAB | 31 | 67% | 5% | 28 |
2 | SUBCONJUNCTIVAL BEVACIZUMAB | 29 | 54% | 6% | 38 |
3 | VASCULARIZED HUMAN CORNEAS | 18 | 89% | 1% | 8 |
4 | LIPID KERATOPATHY | 12 | 63% | 2% | 12 |
5 | SUBCONJUNCTIVAL BEVACIZUMAB INJECTION | 9 | 83% | 1% | 5 |
6 | LYMPHATIC VESSEL GROWTH | 8 | 75% | 1% | 6 |
7 | CORNEAL NEOVASCULARIZATION | 8 | 20% | 6% | 37 |
8 | RAT CORNEA | 7 | 38% | 2% | 14 |
9 | EXPERIMENTAL CORNEAL NEOVASCULARIZATION | 5 | 47% | 1% | 8 |
10 | AVASCULARITY | 5 | 63% | 1% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The association between corneal neovascularization and visual acuity: a systematic review | 2013 | 10 | 24 | 88% |
Corneal Neovascularization: An Anti-VEGF Therapy Review | 2012 | 36 | 129 | 53% |
Treatments for Corneal Neovascularization: A Review | 2011 | 23 | 182 | 53% |
Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable | 2012 | 19 | 72 | 38% |
Anti(lymph)angiogenic Preconditioning Prior to Keratoplasty | 2013 | 2 | 23 | 83% |
Horizons in Therapy for Corneal Angiogenesis | 2011 | 16 | 37 | 41% |
Clinical safety profile of posterior juxtascleral depot administration of anecortave acetate 15 mg suspension as primary therapy or adjunctive therapy with photodynamic therapy for treatment of wet age-related macular degeneration | 2007 | 5 | 7 | 86% |
Anterior segment uses of bevacizumab | 2012 | 7 | 101 | 39% |
Anti-VEGF Therapy With Bevacizumab for Anterior Segment Eye Disease | 2012 | 7 | 157 | 38% |
Preclinical safety of anecortave acetate | 2007 | 3 | 6 | 83% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CORNEAL TISSUE ENGN STEM CELL BIOL | 2 | 33% | 1.0% | 6 |
2 | PENINSULA MED MED DENT | 1 | 100% | 0.3% | 2 |
3 | CORNEA OCULAR SUR E UNIT | 1 | 25% | 0.7% | 4 |
4 | DOHF | 1 | 40% | 0.3% | 2 |
5 | EYE REPAIR | 1 | 40% | 0.3% | 2 |
6 | CLIN IMMUNOL JIANGSU PROV | 1 | 15% | 1.0% | 6 |
7 | ABO STN 2 | 1 | 50% | 0.2% | 1 |
8 | COLOGNE OPHTHALMOL READING IMAGE ANAL CORIC | 1 | 50% | 0.2% | 1 |
9 | FEBRILE DIS | 1 | 50% | 0.2% | 1 |
10 | GOZ HASTALIKLARI KLINIGI | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000157350 | RANIBIZUMAB//INTRAVITREAL INJECTION//PEGAPTANIB |
2 | 0.0000154329 | CORNEAL TRANSPLANTATION//ANTERIOR CHAMBER ASSOCIATED IMMUNE DEVIATION ACAID//ACAID |
3 | 0.0000107125 | CORNEAL WOUND HEALING//KERATOCYTE//KERATOCYTES |
4 | 0.0000100425 | PTERYGIUM//CONJUNCTIVAL AUTOGRAFT//RECURRENT PTERYGIUM |
5 | 0.0000093243 | TETRATHIOMOLYBDATE//ATN 224//ANGIOTROPIN CURNP RIBOKINE |
6 | 0.0000081030 | LYMPHANGIOGENESIS//VEGF C//PODOPLANIN |
7 | 0.0000077667 | INFLAMMAT REGENERAT MED//NONA D ARGININE//CRCERT |
8 | 0.0000075523 | AMNIOTIC MEMBRANE//LIMBAL STEM CELL DEFICIENCY//LIMBAL STEM CELLS |
9 | 0.0000067845 | PEDF//PIGMENT EPITHELIUM DERIVED FACTOR//PIGMENT EPITHELIUM DERIVED FACTOR PEDF |
10 | 0.0000066322 | ENDOSTATIN//ANGIOSTATIN//COLLAGEN XVIII |